Margie Kooman - Science 37 Vice Communications

Executive

Margie Kooman is Vice Communications of Science 37 Holdings
Phone984 377 3737
Webhttps://www.science37.com

Science 37 Management Efficiency

The company has return on total asset (ROA) of (0.2831) % which means that it has lost $0.2831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1852) %, meaning that it created substantial loss on money invested by shareholders. Science 37's management efficiency ratios could be used to measure how well Science 37 manages its routine affairs as well as how well it operates its assets and liabilities.
Science 37 Holdings currently holds 1.32 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Science 37 Holdings has a current ratio of 6.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Science 37's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Arthur NewmanHealthStream
76
Eugene JohnstonMangoceuticals, Common Stock
61
Anand KumarHealthcare Triangle
50
Michael JDHealthStream
49
Jason HoldenForian Inc
N/A
Scott FenstermacherHealthStream
56
Martin FCAFOXO Technologies
68
Timothy CruickshankHeartbeam
43
Michael MDNutex Health
54
Paul ReuscherForian Inc
N/A
Esq JDNutex Health
60
Linda StacyNational Research Corp
54
Vinitha RamnathanNational Research Corp
N/A
Andy MonnichNational Research Corp
49
Mark MillinerNutex Health
N/A
RN BSNHealthStream
49
Jason HahnNational Research Corp
52
Michael CPAForian Inc
63
Michael McQuiggHealthStream
57
Jennifer BaronNational Research Corp
N/A
Richa GujaratiHeartbeam
N/A
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. Science 37 operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 601 people. Science 37 Holdings (SNCE) is traded on NASDAQ Exchange in USA and employs 460 people.

Management Performance

Science 37 Holdings Leadership Team

Elected by the shareholders, the Science 37's board of directors comprises two types of representatives: Science 37 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Science. The board's role is to monitor Science 37's management team and ensure that shareholders' interests are well served. Science 37's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Science 37's outside directors are responsible for providing unbiased perspectives on the board's policies.
Troy Bryenton, Chief Officer
Christine JD, Chief Secretary
David Coman, CEO Director
Mike Zaranek, Chief Officer
Elisa Cascade, Chief Officer
Christopher Ceppi, Chief Officer
Margie Kooman, Vice Communications
Michael Shipton, Chief Officer
Irena Lambridis, VP Compliance
Drew Bustos, Chief Officer
James Young, Chief Officer
Darcy Forman, Chief Officer
Tyler Horn, VP Staff
Jonathan MD, Chief Officer

Science Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Science 37 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Science Stock

If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities